- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.12. | XFRA NEW INSTRUMENTS AVAILABLE ON 05.12.2025 | 465 | Xetra Newsboard | The following instruments on XETRA do have their first trading 05.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 05.12.2025
Aktien
1 US1409351079 CapsoVision Inc.
2... ► Artikel lesen | |
| CAPSOVISION Aktie jetzt für 0€ handeln | |||||
| 14.11. | Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 | 1 | Investing.com | ||
| 14.11. | CapsoVision Q3 Loss Widens As Operating Costs Increase | 3 | RTTNews | ||
| 13.11. | CapsoVision, Inc. GAAP EPS of -$0.17 misses by $0.04, revenue of $3.54M misses by $0.14M | 6 | Seeking Alpha | ||
| 13.11. | CapsoVision, Inc - 10-Q, Quarterly Report | - | SEC Filings | ||
| 10.11. | CapsoVision beantragt FDA-Sonderstatus für Diagnosekapsel zur Bauchspeicheldrüsenkrebs-Früherkennung | 2 | Investing.com Deutsch | ||
| 10.11. | CapsoVision seeks FDA breakthrough status for pancreatic cancer tool | 1 | Investing.com | ||
| 10.11. | CapsoVision, Inc - 8-K, Current Report | - | SEC Filings | ||
| 03.11. | CapsoVision, Inc - 8-K, Current Report | - | SEC Filings | ||
| 30.10. | CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025 | 3 | GlobeNewswire (USA) | ||
| 26.09. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 15.08. | CapsoVision GAAP EPS of -$2.02 misses by $1.91, revenue of $3.32M beats by $0.07M | 1 | Seeking Alpha | ||
| 14.08. | CapsoVision, Inc - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.08. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 29.07. | CapsoVision is a buy, this analyst says | 1 | Cantech Letter | ||
| 28.07. | CapsoVision stock initiated with Speculative Buy rating at Benchmark | 1 | Investing.com | ||
| 28.07. | Benchmark startet Coverage für CapsoVision mit spekulativer Kaufempfehlung | 2 | Investing.com Deutsch | ||
| 28.07. | CapsoVision stock initiated with Buy rating at Roth/MKM on GI imaging potential | 1 | Investing.com | ||
| 18.07. | CapsoVision, Inc - 8-K, Current Report | 2 | SEC Filings |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 19,150 | -1,95 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BILLIONTOONE | 86,34 | -0,84 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,880 | +0,49 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| BRIGHTSPRING HEALTH SERVICES | 37,730 | -0,13 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 25,510 | -0,23 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 136,12 | +0,57 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,690 | -0,17 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| LIFEMD | 4,000 | +15,61 % | Morning Market Movers: Olema Pharmaceuticals, LifeMD, Alpha Technology Group, Intellinetics See Big Swings | HELSINKI (dpa-AFX) - At 8:10 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ADAPTHEALTH | 10,240 | +1,29 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| BETA BIONICS | 31,090 | -0,83 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTFLOW | 30,500 | 0,00 % | Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, Israel Englander, Viking Global, Point72 Asset Management, Heartflow Inc (HTFL), Teva Pharmaceutical Industries Ltd (TEVA), and More | ||
| CERIBELL | 21,420 | +0,61 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| RXSIGHT | 11,460 | +4,09 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CLEARPOINT NEURO | 14,490 | +0,84 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| HEARTBEAM | 2,585 | -5,66 % | Heartbeam stock is a buy, this analyst says |
CAPSOVISION INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -6,36 % bei einem Aktienkurs von 10,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAPSOVISION INC finden Sie auf Wallstreet Online.